Abstract
The kynurenine pathway (KP) and several of its neuroactive products, especially quinolinic acid (QUIN), are considered to be involved in the neuropathogenesis of Alzheimer’s disease (AD). There is growing evidence suggesting that astrocytes play a critical role in the regulation of the excitotoxicity and inflammatory processes that occur during the evolution of AD. This review focuses on the role of astrocytes through their relation with the KP to the different features associated with AD including cytokine, chemokine and, adhesion molecule production, cytoskeletal changes, astrogliosis, excitotoxicity, apoptosis and neurodegeneration.
Similar content being viewed by others
References
Akiyama H, S Barger, S Barnum, B Bradt, J Bauer, GM Cole, NR Cooper, P Eikelenboom, M Emmerling, BL Fiebich, CE Finch, S Frautschy, WS Griffin, H Hampel, M Hull, G Landreth, L Lue, R Mrak, IR Mackenzie, PL McGeer, MK O’Banion, J Pachter, G Pasinetti, C Plata-Salaman, J Rogers, R Rydel, Y Shen, W Streit, R Strohmeyer, I Tooyoma, FL Van Miuswinkel, R Veerhuis, D Walker, S Webster, B Wegrzyniak, G Wenk and T Wyss-Coray (2000) Inflammation and Alzheimer’s disease.Neurobiol. Aging 21, 383–421.
Anderson CM and RA Swanson (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions.Glia 32, 1–14.
Aschner M (1998a) Astrocytes as mediators of immune and inflammatory responses in the CNS.Neurotoxicology 19, 269–281.
Aschner M (1998b) Immune and inflammatory responses in the CNS: modulation by astrocytes.Toxicol. Lett. 102–103, 283–287.
Bacci A, G Sancini, C Verderio, S Armano, E Pravettoni, R Fesce, S Franceschetti and M Matteoli (2002) Block of glutamate-glutamine cycle between astrocytes and neurons inhibits epileptiform activity in hippocampus.J. Neurophysiol. 88, 2302–2310.
Ballabh P, A Braun and M Nedergaard (2004) The blood-brain barrier, an overview: structure, regulation, and clinical implications.Neurobiol. Dis. 16, 1–13.
Baran H, K Jellinger and L Deecke (1999) Kynurenine metabolism in Alzheimer’s disease.J. Neural Transm. 106, 165–181.
Beal MF, WR Matson, KJ Swartz, PH Gamache and ED Bird (1990) Kynurenine pathway measurements in Huntington’s disease striatum: evidence for reduced formation of kynurenic acid.J. Neurochem. 55, 1327–1339.
Bender DA and GM McCreanor (1982) The preferred route of kynurenine metabolism in the rat.Biochim. Biophys. Acta 717, 56–60.
Beninger RJ, AM Colton, JL Ingles, K Jhamandas and RJ Boegman (1994) Picolinic acid blocks the neurotoxic but not the neuroexcitant properties of quinolinic acid in the rat brain: evidence from turning behaviour and tyrosine hydroxylase immunohistochemistry.Neuroscience 61, 603–612.
Benveniste EN (1992) Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action.Am. Physiol. Soc., C1–C16.
Bignami A, LF Eng, D Dahl and CT Uyeda (1976) The astroglial response to stabbing. Immunofluorescence studies with antibodies to astrocyte-specific protein (GFA) in mammalian and sub mammalian vertebrates.Neuropathol. Appl. Neurobiol. 2, 99–100.
Bitterman KJ, RM Anderson, HY Cohen, M Latorre-Esteves and DA Sinclair (2002) Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1.J. Biol. Chem. 277, 45099–45107.
Bjorklund H, L Olson, D Dahl and R Schwarcz (1986) Short-and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes.Brain Res. 371, 267–277.
Blasko I, F Marx, E Steiner, T Hartmann and B Grubeck-Loebenstein (1999) TNFα plus IFNγ induce the production of Alzheimer β-amyloid peptides and decrease the secretion of APPs.FASEB J. 13, 63–68.
Blennow K, MJ de Leon and H Zetterberg (2006) Alzheimer’s disease.Lancet 368, 387–402.
Bosco MC, A Rapisarda, S Massazza, G Melillo, H Young and L Varesio (2000) The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1α and-β in macrophages [In Process Citation].J. Immunol. 164, 3283–3291.
Bovolenta P, RKH Liem and CA Mason (1984) Development of cerebellar astroglia: transitions in form and cytoskeleton content.Dev. Biol. 102, 248–259.
Burkle a (2001) Physiological and pathophysiology of poly(ADP-ribosyl)ation.Bioessays 23, 795–806.
Byun Y, R Chang, M Trivedi, KJ Green and VL Cryns (2001) Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis.Cell Death Differ. 8, 443–450.
Carlin JM, EC Borden, PM Sondel and GI Byrne (1989) Interferon-induced indoleamine 2,3-dioxygenase activity in human mononuclear phagocytes.J. Leukoc. Biol. 45, 29–34.
Cockhill J, K Jhamandas, RJ Boegman and RJ Beninger (1992) Action of picolinic acid and structurally related pyridine carboxylic acids on quinolinic acid-induced cortical cholinergic damage.Brain Res. 599, 57–63.
Cortrina ML and M Nedergaard (2002) Astrocytes in the aging brain.J. Neurosci. Res. 67, 1–10.
Culican SM, NL Baumrind, M Yamamoto and AL Pearlman (1990) Cortical radial glia: identification in tissue culture and evidence for their transformation to astrocytes.J. Neurosci. 10, 684–692.
Cullen KM (1997) Perivascular astrocytes within Alzheimer’s disease plaques.Neuroreport 8, 1961–1966.
da Cunha A, JJ Jefferson, WR Tyor, JD Glass, FS Jannetta and L Vitkovic (1993) Control of astrocytosis by interleukin-1 and transforming growth factor-β1 in human brain.Brain Res. 631, 39–45.
Dallner C, AG Woods, T Deller, M Kirsch and HD Hofinann (2002) CNTF and CNTF receptor alpha are constitutively expressed by astrocytes in the mouse brain.Glia 37, 374–378.
Dong YS and EN Benveniste (2001) Immune function of astrocytes.Glia 36, 180–190.
Drejer J, OM Larsson and A Schousboe (1982) Characterization ofl-glutamate uptake into and release from astrocytes and neurons cultured from different brain regions.Exp. Brain Res. 47, 259–269.
Dyer MA and CL Cepko (2000) Control of Muller glial cell proliferation and activation following retinal injury.Nat. Neurosci. 3, 873–880.
Eastman CL (1989) Cytotoxicity of 3-hydroxykynurenine in a neuronal hybrid cell line.Brain Res. 495, 225–231.
Eddleston M and L Mucke (1993) Molecular profile of reactive astrocytes — implications for their role in neurologic disease.Neuroscience 54, 15–36.
Edwards MA, M Yamamoto and VSJ Caviness (1990) Organization of radial glia and related cells in the developing murine CNS. An analysis based upon a new monoclonal antibody marker.Neuroscience 36, 121–144.
Erecinska M and IA Silver (1990) Metabolism and role of glutamate in mammalian brain.Prog. Neurobiol. 35, 245–296.
Fiala M, QN Liu, J Sayre, V Pop, V Brahmandam, MC Graves and HV Vinters (2002) Cyclooxygenase-2-positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood-brain barrier.Eur. J. Clin. Invest. 32, 360–371.
Fiala M, L Zhang, X Gan, B Sherry, D Taub, MC Graves, S Hama, D Way, M Weinand, M Witte, D Lorton, YM Kuo and AE Roher (1998) Amyloid-β induces chemokine secretion and monocyte migration across a human blood-brain barrier model.Mol. Med. 4, 480–489.
Fierz W, B Endler, K Reske, H Wekerle and A Fontana (1985) Astrocytes as antigen-presenting cells. I. Induction of la antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation.J. Immunol. 134, 3785–3793.
Frohman EM, S van den Noort and S Gupta (1989) Astrocytes and intracerebral immune responses.J. Clin. Immunol. 9, 1–9.
Galou M, E Colucci-Guyon, D Ensergueix, JL Ridet, M Gimenez y Ribotta, A Privat, C Babinet and P Dupouey (1996) Disrupted glial fibrillary acidic protein network in astrocytes from vimentin knockout mice.J. Cell Biol. 133, 853–863.
Gee JR and JN Keller (2005) Astrocytes: regulation of brain homeostasis via apolipoprotein E.Int. J. Biochem. Cell Biol. 37, 1145–1150.
Groves AK, A Entwistle, PS Jat and M Noble (1993) The characterization of astrocyte cell lines that display properties of glial scar tissue.Dev. Biol. 159, 87–104.
Guillemin GJ, SJ Kerr, GA Smythe, PJ Armati and BJ Brew (1999) Kynurenine pathway metabolism in human astrocytes.Adv. Exp. Med. Biol. 467, 125–131.
Guillemin GJ, SJ Kerr, LA Pemberton, DG Smith, GA Smythe, PJ Armati and BJ Brew (2001a) IFN-β1b induces kynurenine pathway metabolism in human macrophages: potential implications for multiple sclerosis treatment.J. Interferon Cytokine Res. 21, 1097–1101.
Guillemin GJ, SJ Kerr, GA Smythe, DG Smith, V Kapoor, PJ Armati, J Croitoru and BJ Brew (2001b) Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection.J. Neurochem. 78, 1–13.
Guillemin GJ, J Croitoru-Lamoury, D Dormont, PJ Armati and BJ Brew (2003a) Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes.Glia 41, 371–381.
Guillemin GJ, DG Smith, GA Smythe, PJ Armati and BJ Brew (2003b) Expression of the kynurenine pathway enzymes in human microglia and macrophages.Adv. Exp. Med. Biol. 527, 105–112.
Guillemin GJ, GA Smythe, LA Veas, O Takikawa and BJ Brew (2003c) Aβ1–42 induces production of quinolinic acid by human macrophages and microglia.Neuroreport 14, 2311–2315.
Guillemin GJ, BJ Brew, CE Noonan, O Takikawa and KM Cullen (2005a) Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer’s disease hippocampus.Neuropathol. Appl. Neurobiol. 31, 395–404.
Guillemin GJ, SJ Kerr and BJ Brew (2005b) Involvement of quinolinic acid in AIDS dementia complex.Neurotox. Res. 7, 103–123.
Guillemin GJ, V Meininger and BJ Brew (2005c) Implications for the kynurenine pathway and quinolinic acid in amytrophic lateral sclerosis.Neurodegenerative Dis 2, 1–11.
Guillemin GJ, L Wang and BJ Brew (2005d) Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex.J. Neuroinflammation 2, 16.
Guillemin GJ, KM Cullen, CK Lim, GA Smythe, V Kapoor, B Garner, O Takikawa and BJ Brew (2007) Characterization of the kynurenine pathway in human neuronProc. Natl. Acad. Sci. USA submitted.
Harpin ML, P Delaere, F Javoy-Agid, E Bock, C Jacque, B Delpech, H Villarroya, C Duyckaerts, JJ Hauw and N Baumann (1990) Glial fibrillary acidic protein and βA4 protein deposits in temporal love of aging brain and senile dementia of the Alzheimer type: relation with the cognitive state and with quantitative studies of senile plaques and neurofibrillary tangles.J. Neurosci. Res 27, 587–594.
Hartai Z, P Klivenyi, T Janaky, B Penke, L Dux and L Vecsei (2005) Kynurenine metabolism in multiple sclerosis.Acta Neurol. Scand. 112, 93–96.
Hartai Z, A Juhasz, A Rimanoczy, T Janaky, T Donko, L Dux, B Penke, GK Toth, Z Janka and J Kalman (2007) Decreased serum and red blood cell kynurenic acid levels in Alzheimer’s disease.Neurochem. Int. 50, 308–313.
Hertz L, R Dringen, A Schousboe and SR Robinson (1999) Astrocytes: glutamate producers for neurons.J. Neurosci. Res. 57, 417–428.
Heyes MP (1996) The kynurenine pathway and neurologic disease. Therapeutic strategies.Adv. Exp. Med. Biol. 398, 125–129.
Heyes MP, BJ Brew, K Saito, BJ Quearry, RW Price, K Lee, RB Bhalla, M Der and SP Markey (1992a) Inter-relationships between quinolinic acid, neuroactive kynurenines, neopterin and β2-microglobulin in cerebrospinal fluid and serum of HIV-1-infected patients.J. Neuroimmunol. 40, 71–80.
Heyes MP, K Saito, JS Crowley, LE Davis, MA Demitrack, M Der, LA Dilling, J Elia, MJ Kruesi, A Lackneret al. (1992b) Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease.Brain 115 (Pt 5), 1249–1273.
Heyes MP, CL Achim, CA Wiley, EO Major, K Saito and SP Markey (1996) Human microglia convert L-tryptophan into the neurotoxin quinolinic acid.Biochem. J. 320, 595–597.
Hinterkeuser S, W Schroder, G Hager, G Seifert, I Blumcke, CE Elger, J Schramm and C Steinhauser (2000) Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances.Eur. J. Neurosci. 12, 2087–2096.
Ilzecka J, T Kocki, Z Stelmasiak and WA Turski (2003) Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis.Acta Neurol. Scand. 107, 412–418.
Jabs, R, IA Paterson and W Walz (1997) Qualitative analysis of membrane currents in glial cells from normal and gliotic tissuein situ.Neuroscience 81, 847–860.
Janeczko K (1992) A comparison of the proliferative activity of astrocytes and astrocyte-like cells expressing vimentin in the injured mouse cerebral hemisphere.Folia Histochem. Cytobiol. 30, 27–33.
Janzer RC and MC Raff (1987) Astrocytes induce blood-brain barrier properties in endothelial cells.Nature 325, 253–257.
Janzer RC and MC Raff (1997) Astrocytes induce blood-brain barrier properties in endothelial cells.Nature 325, 253–257.
Jhamandas K, RJ Boegman, RJ Beninger and M Bialik (1990) Quinolinate-induced cortical cholinergic damage: modulation by tryptophan metabolites.Brain Res. 529, 185–191
Jhamandas KH, RJ Boegman, RJ Beninger, AF Miranda and KA Lipic (2000) Excitotoxicity of quinolinic acid: modulation by endogenous antagonists.Neurotox. Res. 2, 139–155.
Kalisch BE, K Jhamandas, RJ Boegman and RJ Beninger (1994) Picolinic acid protects against quinolinic acid-induced depletion of NADPH diaphorase containing neurons in the rat striatum.Brain Res. 668, 1–8.
Karwoski CJ, HK Lu and EA Newman (1989) Spatial buffering of light-evoked potassium increases by retinal Muller (glial) cells.Science 244, 505–620.
Kashon ML, GW Ross, JP O’Callaghan, DB Miller, H Petrovitch, CM Burchfiel, DS Sharp, WR Markesbery, DG Davis, J Hardman, J Nelson and LR White (2004) Associations of cortical astrogliosis with cognitive performance and dementia status.J. Alzheimers Dis. 6, 595–604.
Kimelberg HK and MD Norenberg (1989) Astrocytes.Sci. Am. 260, 66–72, 74, 76.
Kobayashi K, M Hayashi, H Nakano, M Shimazaki, K Sugimori and Y Koshino (2004) Correlation between astrocyte apoptosis and Alzheimer changes in gray matter lesions in Alzheimer’s disease.J. Alzheimers Dis. 6, 623–632.
Kuchler-Bopp S, JP Delanoy, JC Artault, M Zaepfel and JR Dietrich (1999) Astrocytes induce several blood-brain barrier properties in non-neural endothelial cells.Neuroreport 10, 1347–1353.
Lange H, H Thorner, A Hopf and KF Schroeder (1978) Morphometric studies of the neuropathological changes in choreatic disease.J. Neurol. Sci. 28, 401–425.
Lapin IP, IB Prakhie and IP Kiseleva (1982) Excitatory effects of kynurenine and its metabolites, amino acids and convulsants administered into brain ventricles: differences between rats and mice.J. Neural Transm. 54, 229–238.
Laping NJ, B Teter, NR Nichols, I Rozovsky and CE Finch (1994) Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors.Brain Pathol. 1, 259–275.
Laterra J and GW Goldstein (1991) Astrocytes-inducedin vitro angiogenesis: requirements for RNA and protein synthesis.J Neurochem. 57, 1231–1239.
Le Prince G, P Delaere, C Fages, C Duyckaerts, JJ Hauw and M Tardy (1993) Alterations of glial fibrillary acidic protein mRNA level in the aging brain and in senile dementia of the Alzheimer type.Neurosci. Lett. 151, 71–73.
Lesne S, C Ali, C Gabriel, N Croci, ET MacKenzie, CG Glabe, M Plotkine, C Marchand-Verrecchia, D Vivien and A Buisson (2005) NMDA receptor activation inhibits α-secretase and promotes neuronal amyloid-β production.J. Neurosci. 25, 9367–9377.
Lim CK, GA Smythe, R Stocker, BJ Brew and GJ Guillemin (2007) Characterization of the kynurenine pathway in human oligodendrocytes.Intl. Congr Series. In press
Luo J, AY Nikolaev, S Imai, D Chen, F Su, A Shiloh, L Guarente and W Gu (2001) Negative control of p53 by Siralpha promotes cell survival under stress.Cell 107, 137–148.
Magistretti PJ and L Pellerin (2000) [Functional brain imaging: role metabolic coupling between astrocytes and neurons.].Rev. Med. Suisse Romande 120, 739–742.
Malhotra SK and TK Shnitka (2002) Diversity of reactive astrocytes, In:Neuroglia in the Aging Brain (de Vellis JS, Ed.) (Human Press, Totowa, NJ) pp 17–33.
Maragakis NJ and JD Rothstein (2006) Mechanisms of disease: astrocytes in neurodegenerative disease.Nature 2, 679–689.
Marcaggi P and JA Coles (2001) Ammonium in nervous tissue: transport across cell membranes, fluxes from neurons to glial cells, and role in signaling.prog. Neurobiol. 64, 157–183.
Marshak DR, SA Pesce, LC Stanley and WS Griffin (1992) Increased S100β neurotrophic activity in Alzheimer’s disease temporal lobe.Neurobiol. Aging 13, 1–7.
Matthew CK, KE Van Holde and KG Ahern (2003)Biochemistry (Addison-Wesley: Boston).
McGeer EG and PL McGeer (2003) Inflammatory processes in Alzheimer’s disease.prog. Neuro-Psych. Biol. Psych. 27, 741–749.
Melillo G, MC Bosco, T Musso and L Varesio (1996) Immunobiology of picolinic acid.Adv. Exp. Med. Biol. 398, 135–141.
Melillo G, GW Cox, D Radzioch and L Varesio (1993) Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages.J. Immunol. 150, 4031–4040.
Mellor AL, B Baban, P Chandler, B Marshall, K Jhaver, A Hansen, PA Koni, M Iwashima and DH Munn (2003) Cutting edge: induced indoleamine 2,3 dioxygenase expression in dendritic cell subsets suppresses T cell clonal expansion.J. Immunol. 171, 1652–1655.
Miller RH, S David, R Patel, ER Abney and MC Raff (1985) A quantitative immunohistochemical study of macroglial cell development in the rat optic nerve:in vivo evidence for two distinct astrocyte lineages.Dev. Biol. 111, 35–41.
Misson JP, MA Edwards, M Yamamoto and VSJ Caviness (1988) Identification of radial glial cells within the developing murine central nervous system: studies based upon a new immunohistochemical marker.Brain Res. Dev. Brain Res. 44, 95–108.
Moffett JR and MA Namboodiri (2003) Tryptophan and the immune response.Immunol. Cell Biol. 81, 247–265.
Moroni F (1999) Tryptophan metabolism and brain function: focus on kynurenine and other indole metabolites [In Process Citation].Eur. J. Pharmacol. 375, 87–100.
Moroni F, A Cozzi, F Peruginelli, R Carpenedo and DE Pellegrini-Giampietro (1999) Neuroprotective effects of kynurenine-3-hydroxylase inhibitors in models of brain ischemia.Adv. Exp. Med. Biol. 467, 199–206.
Mouser PE, E Head, KH Ha and TT Rohn (2006) Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer’s disease brain.Am J Pathol. 168, 936–946.
Moynagh PN, DC Williams and LAJO Neil (1994) Activation of NF-κB and induction of vascular cell adhesion molecule-1 and intracellular adhesion molecule-1 expression in human glial cells by IL-1-modulation by antioxidants.J. Immunol. 153, 2681–2690.
Ohta K, A Fujinami, S Kuno, A Sakakimoto, H Matsui, Y Kawahara and M Ohta (2004) Cabergoline stimulates synthesis and secretion of nerve growth factor, brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor by mouse astrocytes in primary culture.Pharmacology 71, 162–168.
Orte C, JG Lawrenson, TM Finn, AR Reid and GA Alit (1999). Comparison of blood-brain barrier and blood-nerve barrier endothelial cell markers.Anat. Embryol (Berl) 199, 509–517.
Owe-Young R, M Mukhtar, R Pomerantz, GA Smythe, D Walker and BJ Brew (2007) Activation of the kynurenine pathway at the blood-brain barrier: a mechanism for persistence of HIV in the brain? In14th Conf Retroviruses and Opportunistic Infections, pp 356.
Petito CK, S Morgello, JC Felix and ML Lesser (1990) The two patterns of reactive astrocytes in postischemic rat brain.J Cereb. Blood Flow Metab. 10, 850–859.
Pike CJ, BJ Cummings and CW Cotman (1995) Early association of reactive astrocytes with senile plaques in Alzheimer’s disease.Exp. Neurol. 132, 172–179.
Pindon A, M Berry and D Antai (2000) Throm bomodulin as a new marker of lesion-induced astrogliosis: involvement of thrombin through the G-protein-coupled protease-activated receptor-1.J. Neurosci. 20, 2543–2550.
Pixley SKR and J de Vellis (1984) Transition between immature radial glia and mature astrocytes studied with a monoclonal antibody to vimentin.Dev. Brain Res. 15, 201–209.
Poitry-Yamate CL, S Poitry and M Tsacopoulos (1995) Lactate released by Muller glial cells is metabolized by photoreceptors from mammalian retina.J. Neurosci. 15, 5179–5191.
Poitry S, CL Poitry-Yamate, J Ueberfeld, PR MacLeish and M Tsacopoulos (2000) Mechanisms of glutamate signaling in retinal glial (Muller) cells.J. Neurosci. 20, 1809–1821.
Porter RJ, BS Lunn and JT O’Brien (2003) Effects of acute tryptophan depletion on cognitive function in Alzheimer’s disease and in the healthy elderly.Psychol. Med. 33, 41–49.
Privat A and P Rataboul (1986)Fibrous and Protoplasmic Astrocytes, vol.1 (Academic Press, San Diego, California)
Qin Z, Y Wang and TN Chase (2000) A caspase-3-like protease is involved in NF-κB activation induced by stimulation ofN-methyl-D-aspartate receptors in rat striatum.Brain Res. Mol. Brain Res 80, 111–122.
Raff MC, RH Miller and M Noble (1983) A glial progenitor cell that developsin vitro into an astrocyte or an oligodendrocyte depending on the culture medium.Nature 303, 390–396.
Risau W and H Wolburg (1990) Development of blood-brain barrier.Trends. Neurosci. 13, 174–194.
Rongvaux A, F Andris, FV Gool and O Leo (2003) Reconstructing eukaryotic NAD metabolism.Bioessays 25, 683–690.
Rothermundt M, M Peters, J Prehn and V Arolt (2003) S100B in brain damage and neurodegeneration.Microsc. Res. Tech. 60, 614–632.
Rutter J, M Reick, LC Wu and SL McKnight (2001) Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors.Science 293, 510–514.
Sardar AM, JE Bell and GP Reynolds (1995) Increased concentrations of the neurotoxin 3-hydroxykynurenine in the frontal cortex of HIV-1-positive patients.J. Neurochem. 64, 932–935.
Schmechel DE and P Rakic (1979) A golgi study of radial glial cells in developing monkey telencephalon: morphongenesis and transformation into astrocytes.Anat. Embryol. (Berl.) 156, 115–152.
Schwartz JP and K Mishler (1990) β-Adrenergic receptor regulation, through cyclic AMP, of nerve growth factor expression in rat cortical and cerebellar astrocytes.Cell Mol Neurobiol. 10, 447–457.
Schwarz M, S Teipel, K Burger and H Hampel (2006) Elevated 3-hydroxykynurenine serum levels in Alzheimer’s disease, In:Stress Behaviour Immune Response (Greisfivald: Germany).
Seifert G and C Steinhauser (1995) Glial cells in the mouse hippocampus express AMPA receptors with an intermediate Ca2+ permeability.Eur. J. Neurosci. 7, 1872–1881.
Smith JS and JD Boeke (1997) An unusual form of transcriptional silencing in yeast ribosomal DNA.Genes Dev. 11, 241–254.
Stone TW (1993) Neuropharmacology of quinolinic and kynurenic acids.Pharmacol. Rev. 45, 309–379.
Stone TW (2001) Endogenous neurotoxins from tryptophan.Toxicon 39, 61–73.
Stoy N, GM Mackay, CM Forrest, J Christofides, M Egerton, TW Stone and LG Darlington (2005) Tryptophan metabolism and oxidative stress in patients with Huntington’s disease.J. Neurochem. 93, 611–623.
Takamiya Y, S Kohsaka, S Toya, M Otani and Y Tsukada (1988) Immunohistochemical studies on the proliferation of reactive astrocytes and the expression of cytoskeletal proteins following brain injury in rats.Brain Res. 466, 201–210.
Takikawa O (2005) Biochemical and medical aspects of the indoleamine 2,3-dioxygenase-initiated 1-tryptophan metabolism.Biochem. Biophys. Res. Commun. 338, 12–19.
Tavares RG, CI Tasca, CE Santos, M Wajner, DO Souza and CS Dutra-Filho (2000) Quinolinic acid inhibits glutamate uptake into synaptic vesicles from rat brain.Neuroreport 11, 249–253.
Tavares RG, CI Tasca, CE Santos, LB Alves, LO Porciuncula, T Emanuelli and DO Souza (2002) Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes.Neurochem. Int. 40, 621–627.
Testa U, F Louache, M Titeux, P Thompoulos and H Rochant (1985) The iron-chelating agent picolinic acid enhances transferrin receptors expression in human erythroleukaemic cell lines.Br. J. Haematol. 60, 491–502.
Urenjak J and TP Obrenovitch (2000) Neuroprotective potency of kynurenic acid against excitotoxicity.Neuroreport 11, 1341–1344.
Vaziri H, SK Dessain, EE Ng, SI Imai, RA Frye, TK Pandita. L Guarente and RA Weinberg (2001) hSIR2(SIRT1) functions as an NAD-dependent p52 deacetylase.Cell 107, 149–159.
Viviani B, S Bartesaghi, E Corsini, CL Galli and M Marinovich (2004) Cytokines role in neurogenerative events.Toxicol. Lett. 149, 85–89.
Vrooman L, K Jhamandas, RJ Boegman and RJ Beninger (1993) Picolinic acid modulates kainic acid-evoked glutamate release from the striatumin vitro.Brain Res. 627, 193–198.
Walz W (1989) Role of glial cells in the regulation of the brain ion microenvironment.Prog. Neurobiol. 33, 309–333.
Walz W (2000) Controversy surrounding the existence of discrete functional classes of astrocytes in adult gray matter.Glia 31, 95–103.
Weiner HL and D Frenkel (2006) Immunology and immunotherapy of Alzheimer’s disease.Nature 6 404–416.
Widner B, F Leblhuber, J Walli, GP Tilz, U Demel and D Fuchs (2000) Tryptophan degradation and immune activation in Alzheimer’s disease.J. Neural Transm. 107, 343–353.
Wilkinson A, J Day and R Bowater (2001) Bacterial DNA ligases.Mol. Microbiol. 40, 1241–1248.
Yankner BA, (1996) Mechanisms of neuronal degeneration in Alzheimer’s disease.Neuron 16, 921–932.
Yasuda Y, N Tateishi, T Shimoda, S Satoh, E Ogitani and S Fujita (2004) Relationship between S100β and GFAP expression in astrocytes during infarction and glial scar formation after mild transient ischemia.Brain Res 1021, 20–31.
Yu AC, A Schousboe and L Hertz (1982) Metabolic fate of 14C-labeled glutamate in astrocytes in primary cultures.J. Neurochem. 39, 954–960.
Zhou M, GP Schools and HK Kimelberg (2000) GFAP mRNA positive glia isolated from rat hippocampus predominantly show complex current patterns.Brain Res. Mol. Brain Res. 76, 121–131.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ting, K.K., Brew, B. & Guillemin, G. The involvement of astrocytes and kynurenine pathway in Alzheimer’s disease. neurotox res 12, 247–262 (2007). https://doi.org/10.1007/BF03033908
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03033908